Clinical Trial Update: Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether zoledronic acid reduces lung metastases in osteosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Metastases
• Osteosarcoma

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Lung Metastases, Tumor Necrosis | Phase 4 | Status: UNKNOWN